{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:02:01Z","timestamp":1793746921441,"version":"4.6.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.amjcard.2016.06.038","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T14:04:21Z","timestamp":1467036261000},"page":"881-887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"118","author":[{"given":"Hannah G.","family":"van Velzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"Vriesendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier A.","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon A.","family":"van Slegtenhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend F.L.","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2016.06.038_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jacc.2014.05.003","article-title":"Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine","volume":"64","author":"Maron","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.06.038_bib2","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A\u00a0systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2016.06.038_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/cvr\/cvv025","article-title":"Genetic advances in sarcomeric cardiomyopathies: state of the art","volume":"105","author":"Ho","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjcard.2016.06.038_bib4","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2016.06.038_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jchf.2013.08.007","article-title":"Sarcomere gene mutations are associated with increased cardiovascular events in left ventricular hypertrophy: results from multicenter registration in Japan","volume":"1","author":"Fujita","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2016.06.038_bib6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/heartjnl-2014-306387","article-title":"Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy","volume":"101","author":"Lopes","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2016.06.038_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCGENETICS.113.000331","article-title":"Genotype-positive status in patients with hypertrophic cardiomyopathy is associated with higher rates of heart failure events","volume":"7","author":"Li","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.amjcard.2016.06.038_bib8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0025-6196(11)60890-2","article-title":"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy","volume":"83","author":"Olivotto","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2016.06.038_bib9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"29","author":"Plon","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.amjcard.2016.06.038_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF03091771","article-title":"Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands","volume":"18","author":"Christiaans","year":"2010","journal-title":"Neth Heart J"},{"key":"10.1016\/j.amjcard.2016.06.038_bib11","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0195-668X(03)00466-4","article-title":"The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands","volume":"24","author":"Alders","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2016.06.038_bib12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.06.038_bib13","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.jtcvs.2011.10.020","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"142","author":"Gersh","year":"2011","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2016.06.038_bib14","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"van Dijk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.06.038_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00424-013-1432-8","article-title":"Earning stripes: myosin binding protein-C interactions with actin","volume":"466","author":"van Dijk","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.amjcard.2016.06.038_bib16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvt119","article-title":"Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy","volume":"99","author":"Witjas-Paalberends","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjcard.2016.06.038_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/cvr\/cvv023","article-title":"Targets for therapy in sarcomeric cardiomyopathies","volume":"105","author":"Tardiff","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjcard.2016.06.038_bib18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.amjcard.2016.06.038_bib19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.06.038_bib20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1136\/heartjnl-2013-305471","article-title":"Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy","volume":"100","author":"Ismail","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2016.06.038_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.06.038_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jchf.2014.06.012","article-title":"Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy","volume":"2","author":"Vriesendorp","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2016.06.038_bib23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/eurheartj\/ehv122","volume":"36","author":"Mogensen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2016.06.038_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.amjcard.2016.06.038_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","article-title":"Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging","volume":"5","author":"Olivotto","year":"2012","journal-title":"Circ Heart Fail"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916311092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916311092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T18:58:38Z","timestamp":1536605918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914916311092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0002914916311092"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.06.038","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}